Yasir B. Al-Wakeel

Yasir B. Al-Wakeel, listed as finance chief, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Kronos Bio, Inc., Neon Therapeutics, Inc. and Maxcyte, Inc. In total, 17 filings cover trades dated from 17 July 2018 to 17 June 2026.

Market trades split into 1 purchase (€85k) and 2 sales (€30k). The net balance comes to €55k on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 12 share grants and 1 option exercise.

The record was last updated on 22 June 2026 with a share grant in Maxcyte, Inc. The most recent open-market purchase was published on 16 October 2020, 2,198 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.